CA A Cancer Journal for Clinicians· 2020Q1
Kolorektal Kanser İstatistikleri, 2020
Colorectal cancer statistics, 2020
- 5.144atıf
- Q1SCImago
- 2020yıl
Kısa özet
2020'de ABD'de yaklaşık 147.950 kişiye kolorektal kanser (KRK) teşhisi konulacak ve 53.200 kişi bu hastalıktan ölecek; 50 yaş altı bireylerde görülme sıklığı yıllık %2 oranında artıyor.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- 2020'de ABD'de yaklaşık 147.950 yeni kolorektal kanser (KRK) vakası ve 53.200 ölüm beklenmektedir.
- 50 yaş altı bireylerde KRK görülme sıklığı yıllık yaklaşık %2 oranında artmaktadır.
- Ölüm oranları yaşlılarda (65+) düşerken, 50 yaş altı bireylerde artmaktadır.
- KRK görülme sıklığı ırk/etnik kökene göre önemli ölçüde değişmektedir; Alaska Yerlilerinde en yüksek oranlar görülmektedir.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population-based cancer registries and mortality data (through 2017) from the National Center for Health Statistics. In 2020, approximately 147,950 individuals will be diagnosed with CRC and 53,200 will die from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years. The incidence rate during 2012 through 2016 ranged from 30 (per 100,000 persons) in Asian/Pacific Islanders to 45.7 in blacks and 89 in Alaska Natives. Rapid declines in incidence among screening-aged individuals during the 2000s continued during 2011 through 2016 in those aged 65 years and older (by 3.3% annually) but reversed in those aged 50 to 64 years, among whom rates increased by 1% annually. Among individuals aged younger than 50 years, the incidence rate increased by approximately 2% annually for tumors in the proximal and distal colon, as well as the rectum, driven by trends in non-Hispanic whites. CRC death rates during 2008 through 2017 declined by 3% annually in individuals aged 65 years and older and by 0.6% annually in individuals aged 50 to 64 years while increasing by 1.3% annually in those aged younger than 50 years. Mortality declines among individuals aged 50 years and older were steepest among blacks, who also had the only decreasing trend among those aged younger than 50 years, and excluded American Indians/Alaska Natives, among whom rates remained stable. Progress against CRC can be accelerated by increasing access to guideline-recommended screening and high-quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle-aged adults.
Yazarların özeti; kaynağından alınmıştır. CA A Cancer Journal for Clinicians, 2020 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Onkoloji
OncologyMedicine